NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing for Approval of its Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; NovelStem Initiates Process to Become Publicly-Reporting with S.E.C. and to Up-List its Shares
01. Dezember 2020 08:33 ET
|
NovelStem International Corp.
BOCA RATON, Fla. and JERUSALEM, Dec. 01, 2020 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on its stem cell-based technology platform,...
NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and COVID-19 Resistance; Reports Progress Identifying Genetic Resistance to Additional Anti-Cancer Treatments
21. April 2020 08:30 ET
|
NovelStem International Corp.
Screening of resistance diagnostics completed for twelve standard-of-care cancer treatments representing a significant portion of cancer treatment protocols. COVID-19 research collaboration initiated...
NovelStem Increases NewStem Ownership to 27.3% Following Achievement of Development Milestones for Stem-Cell-Based Cancer Treatments Resistance Diagnostic
16. Dezember 2019 08:07 ET
|
NovelStem International Corp.
BOCA RATON, Fla. and JERUSALEM, Israel, Dec. 16, 2019 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on stem-cell-based diagnostic technology to...
NovelStem Provides Shareholder Update
08. Mai 2019 08:03 ET
|
NovelStem International Corp.
BOCA RATON, Fla., May 08, 2019 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM) is focused on the substantial commercial potential of stem-cell-based diagnostic technology to aid...
Hollywood Media Changes Name and Stock Symbol to NovelStem International Corp. and “NSTM” to Reflect Focus on Stem Cell-Based Diagnostics to Better Select Cancer Chemotherapies
25. September 2018 16:02 ET
|
NovelStem International Corp.
BOCA RATON, Fla. and JERUSALEM, Israel, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Hollywood Media Corp. (OTC Pink: HOLL) announced today it has changed its corporate name to NovelStem International Corp....
Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer of Haploid Stem Cell-Based Diagnostics to Predict Chemotherapy Resistance
16. Juli 2018 01:00 ET
|
Hollywood Media Corp.
Raises $1.925 Million to Support a $2 Million Initial Investment in NewStem Ltd.Appoints New Board of Directors Led by Jan Loeb as ChairmanForms New Leadership Team with Deep Healthcare ExpertisePlans...
Hollywood Media Advances Pay Date to March 29 for $0.45 per Share Special Distribution
15. März 2018 15:03 ET
|
Hollywood Media Corp.
BOCA RATON, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- Hollywood Media Corp. (OTC Pink:HOLL) today provided updated timing for the record date, pay date and ex-dividend date for its previously...
Hollywood Media Provides Update on Mechanics of Special One-Time Distribution of $0.45 Per Share
01. März 2018 09:37 ET
|
Hollywood Media Corp.
BOCA RATON, Fla., March 01, 2018 (GLOBE NEWSWIRE) -- Hollywood Media Corp. (OTC Pink:HOLL) today provided an update to clarify the treatment of the special $0.45 per share cash distribution to...
Hollywood Media Corp. to Distribute $0.45 per Share to Shareholders and Focus on Realizing Value of Remaining Assets, Including Netco Partners JV, and Approves 1 Million Share Repurchase Plan
16. Januar 2018 16:01 ET
|
Hollywood Media Corp.
BOCA RATON, Fla., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Hollywood Media Corp. (OTC Pink:HOLL) today announced a $0.45 per share cash distribution to its shareholders following the recently completed...